A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091

Clinical trial NCT05128591 · COMPLETED

Trial details

NCT number: NCT05128591
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Embolism and Thrombosis

Start date: 2021-11-09
Primary completion: 2021-12-31
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.